HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Shorr, A. F. Articles by Owens, R. C. Search for Related Content PubMed PubMed Citation Articles by Shorr, A. F. Articles by Owens, R. C., Jr.

ANDREW F. SHORR, M.D., M.P.H., is Associate Director, Pulmonary Critical Care, Department of Medicine, Washington Hospital Center, Washington, DC. ROBERT C. OWENS JR., PHARM.D., is Co-Director, Antimicrobial Stewardship Program, Department of Pharmacy, and Clinical Pharmacy Specialist, Infectious Diseases, Division of Infectious Diseases, Maine Medical Center, Portland, ME.

Address correspondence to Dr. Shorr at the Department of Medicine, Washington Hospital Center, 110 Irving Street, NW, Washington, DC 20010 (afshorr{at}dnamail.com).

Purpose. The rationales for and recent updates on quality measures for the treatment of community-acquired pneumonia (CAP) are reviewed. Summary. CAP continues to be among the most common causes of emergency department visits, hospitalization, and death in the United States. The Joint Commission of Accredited Health Care Organizations in conjunction with the Centers for Medicare and Medicaid Services (CMS) and the Infectious Diseases Society of America have published seven quality measures designed to improve the overall treatment of CAP. To encourage and enforce compliance with the measures, adherence is publicly reported, and several measures are used in the CMS pay-per-performance initiative. The quality measures are oxygen assessment, pneumococcal conjugate vaccination, blood cultures, adult smoking cessation advice/counseling, antimicrobial timing, initial antimicrobial selection in immunocompetent intensive care unit (ICU) and non-ICU patients, and influenza vaccination. Conclusion. The Joint Commission, CMS, and IDSA guidelines for the management of patients with CAP address basic aspects of preventive care and treatment for CAP. The guidelines emphasize the importance of vaccination as well as the need for appropriate and timely antimicrobial therapy. Adherence to guidelines is associated with improved patient outcomes, and compliance is being enforced by public reporting and pay-per-performance measures. Index terms: Antiinfective agents; Centers for Medicare and Medicaid Services; Community acquired infections; Compliance; Immunization; Infectious Diseases Society of America; Joint Commission on Accreditation of Healthcare Organizations; Pneumococcal infections; Pneumococcal vaccines; Pneumonia; Protocols; Quality assurance; Vaccines

 

This article has been cited by other articles:

				D. Morgenstern and C. S. Garcia-Curiel Clarifications about pneumococcal vaccines Am. J. Health Syst. Pharm., February 1, 2010; 67(3): 183 - 184. [Full Text] [PDF]